Skip to main content
. 2021 Mar 19;13(3):413. doi: 10.3390/pharmaceutics13030413
KT Kidney Transplantation
OPTN Organ Procurement and Transplantation Network
DM Diabetes Mellitus
USRDS United States Renal Data System
PTDM Post-transplant diabetes mellitus
NODAT New onset diabetes after transplantation
OGTT Oral glucose tolerance test
TAH Transplant-associated hyperglycemia
IFG Impaired fasting glucose
IGT Impaired glucose tolerance
ADA American Diabetes Association
WHO World Health Organization
FPG Fasting plasma glucose
HbA1C Hemoglobin A1C
CV Cardiovascular
GFR Glomerular Filtration Rate
T2DM Type 2 DM
HLA Human leukocyte antigen
GLP-1 Glucagon-like peptide 1
CNI Calcineurin inhibitors
mTOR Mammalian target of rapamycin
CMV Cytomegalovirus
PPAR Proliferator-activated receptor
DDP-4 Dipeptidyl Peptidase 4
SGLT2 Sodium-glucose cotransporter type 2
NSAIDs Nonsteroidal anti-inflammatory drugs
P-gp P-glycloprotein
Nrf2 Nuclear factor erythroid 2-related factor
HO-1 Heme oxygenase 1
G6PD Glucose 6 phosphate dehydrogenase
TXNRD1 Thioredoxin reductase 1
DMF Dimethyl Fumarate